Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects
Abstract There are no therapeutics that directly enhance chronic endothelial nitric oxide (NO) release, which is typically associated with vascular homeostasis. In contrast, angiotensin II (AngII) receptor type 1 (AT1R) blockers (ARBs) can attenuate AngII-mediated oxidative stress, which often leads...
Main Authors: | Arash Y. Tehrani, Zoe White, Lin Wei Tung, Roy Ru Yi Zhao, Nadia Milad, Michael A. Seidman, Elodie Sauge, Marine Theret, Fabio M. V. Rossi, Mitra Esfandiarei, Casey van Breemen, Pascal Bernatchez |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-13772-3 |
Similar Items
-
Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice
by: Zoe White, et al.
Published: (2022-02-01) -
Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B.
by: Zoe White, et al.
Published: (2019-01-01) -
ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01) -
Review: Angiotensin Peptides and their Pleiotropic Actions
by: Ion Haulica, et al.
Published: (2005-09-01) -
Blocker, angiotensin II receptor olmesartan to interrupt cardiovascular continuum: vesselsand cardioprotective, anti-atherosclerotic and metabolic pleiotropic effects (part 2)
by: M. G Bubnova
Published: (2015-03-01)